You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The firm said its test eliminates the need for automated extraction systems in a high-volume PCR laboratory, reducing processing time, cost, and labor.
The firm will use the funds primarily to expand a beta program supporting a full commercial launch of its first platform, the Miro Canvas sample prep system.
The firm said its revenues for the three months ended Dec. 31, 2020 were $78.3 million compared to $62.9 million in the same quarter of 2019.
The immune cell sequencing company beat Wall Street estimates on the top line, but missed on the bottom line for both Q4 and full-year 2020.
The company reported $58.6 million in total revenues for the quarter and said testing services revenues rose 73 percent year over year.
The drugstore will sell Pixel by Labcorp kits in up to 6,000 stores, with the goal of providing a testing option at stores that don't currently have on-site testing.
The polygenic risk test analyzes an individual's genes for more than 100,000 SNPs associated with the risk of developing Alzheimer's disease.
Researchers identified new cell cycle proteins and their expression through single-cell transcriptome sequencing, proteomic, and other approaches.
The companies will use their respective technologies and expertise to identify multi-gene biomarkers that can be used in cancer drug discovery.
Investigators detected more than 100 risk loci for primary open-angle glaucoma, with mostly similar effects in people with European, Asian, or African ancestry.
The partners will develop a test to identify women most likely to benefit from VGX-3100, Inovio's immunotherapy to treat HPV-associated advanced cervical dysplasia.
The firm reported revenues of $126.0 million for the three-month period ended Dec. 31, 2020, up from $106.9 million in the same period last year.
The firm guided for 2021 revenue growth of between 5 percent and 8 percent, citing "a persistently uncertain business environment."
The Chinese company said it would use some of the funding to advance its integrated diagnostics research and development pipeline.
RenalytixAI will provide financial support to the University of Utah in the form of sponsored research into kidney disease progression, treatment, and biomarkers.
Total revenues for the period were $154.6 million, down from $195.1 million but beating the consensus Wall Street estimate.
Laboratory staffing and supply shortages limited patient access to cancer screening tests, and the pandemic decreased the development and validation of new tests.
G+FLAS said it provides CRISPR-related research services, tools, and reagents and applies CRISPR technology to develop drugs and produce genome-edited plants.
A pair of studies published this week present an analysis of a real, large-scale testing pooling effort as well as analyses of how to further improve such strategies.
The platform, based on the firm's Hi-C technology, is designed to assembly viral genomes from metagenomic samples and associate them with their microbial hosts.
The Paris-based company plans to use the nucleic acid modification technology to synthesize qPCR probes for use in diagnostics, among other biomolecules.
The Epidemiology of Young Lung Cancer study will build on a prior genomics study to better characterize NSCLC patients diagnosed before age 40.
The expanded partnership includes a commercial agreement for the ClonoSeq and ImmunoSeq assays, as well as a lab service agreement for the T-Detect COVID test.
Genomenon will integrate its AI-driven Mastermind search engine into the BC|Genome and BC|Insight platforms.
The lab will use its phlebotomy network to help Grail with specimen collection for its Galleri multi-cancer early detection blood test, slated to launch this year.
Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.
The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.
The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.
In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.